Latanoprost Stada (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, which remodels the extracellular matrix and increases uveoscleral outflow of aqueous humor. This enhanced outflow lowers intra‑ocular pressure.

The dosing regimen for Latanoprost Stada is determined by the prescribing clinician. Typically, a single drop is instilled into the affected eye(s) once daily in the evening, but the exact schedule should follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To request Latanoprost Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blockers or carbonic anhydrase inhibitors, prostaglandin analogs often achieve greater pressure reduction with a favorable dosing convenience.

Latanoprost Stada should be stored at ambient temperature, protected from light and moisture. Keep the bottle in its original packaging and avoid freezing. If the product appears discolored or the container is damaged, it should not be used.

Latanoprost Stada is administered as an ophthalmic solution. The patient places one drop into each prescribed eye, usually in the evening, without touching the tip of the bottle to the eye or surrounding tissues.

Serious risks include severe ocular inflammation (uveitis), macular edema, and rare allergic reactions that may affect vision. Patients should seek immediate medical attention if they experience sudden vision loss, intense eye pain, or signs of an allergic response.

Latanoprost Stada is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. Caution is advised for individuals with active ocular infections, recent ocular surgery, or those who are pregnant or breastfeeding without clear benefit.